TM4SF5 and hepatocellular carcinoma: Although patients with HCC generally show lower serum ALB levels that are associated with poor survivals3, TM4SF5-mediated patients with HCC (that is, patients with HCC with TM4SF5 increases over nontumor samples) showed increased ALB mRNA and protein expression in the liver (Fig. 6a,b).